Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Motivational Interviewing to Increase Physical Activity to Treat Depression in People Aging With MS or SCI [NA]
This clinical trial update notes a completed study evaluating motivational interviewing to boost physical activity as a treatment for depres…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex [Phase 2]
Phase 2 study evaluating BIIB033 in participants with relapsing forms of multiple sclerosis when used concurrently with Avonex; results have…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis [Phase 1, Phase 2]
This is a completed Phase 1/Phase 2 clinical trial evaluating alpha-lipoic acid and omega-3 fatty acids for cognitive impairment in multiple…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome [Phase 1, Phase 2]
A completed Phase 1/2 trial assessed dose-related effects of Vitamin D3 on immune responses in patients with Clinically Isolated Syndrome an…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Safety and Efficacy Study of Autologus Bone Marrow Mesenchymal Stem Cells in Multiple Sclerosis [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating the safety and efficacy of autologous bone marrow–derived mesenchymal stem cells in people with multi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: The Effect of Melatonin on Gene Expression and Activity of the Sirt1 and Its Target Genes Catalase and MnSOD in Multiple Sclerosis Patients and Healthy Subjects [NA]
This completed trial evaluated the effect of melatonin on Sirt1 expression and activity and on its target genes catalase and MnSOD in indivi…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: An Online Self-Guided Meditation Course for Individuals With Multiple Sclerosis [NA]
Completed clinical trial evaluating an online self-guided meditation course for individuals with Multiple Sclerosis.
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Pulse ACTH vs. MP for MS [Phase 1]
Phase 1 trial comparing pulse adrenocorticotropic hormone (ACTH) versus methylprednisolone for multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: ATX-MS-1467 in Multiple Sclerosis [Phase 2]
Phase 2 clinical trial update for ATX-MS-1467 in multiple sclerosis; the study completed and results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Improved Detection of Multiple Sclerosis Plaques in Inversion Recovery by Optimization of Sequence Parameters
A completed clinical trial update reports improved detection of Multiple Sclerosis plaques by optimizing inversion recovery MRI sequence par…
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Examining the Effects of Video-game Exercise on Mobility and Brain Plasticity in Individuals With Multiple Sclerosis [NA]
A completed clinical trial at Ohio State University evaluating the effects of video-game-based exercise on mobility and brain plasticity in …
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS
A completed clinical trial investigating the conversion to multiple sclerosis in female monozygotic twins discordant for clinically isolated…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Study of Social Cognition by Morphological and Functional Imaging in Multiple Sclerosis Patients [NA]
This clinical trial update notes the completion of a study examining social cognition in Multiple Sclerosis patients using morphological and…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Efficacy Study of "Imaginative Distention", a Self Managed Tool to Cope With Fatigue,Insomnia and Stress in pw Insomnia and pw MS [NA]
The trial evaluated a self-managed tool called 'Imaginative Distention' for coping with fatigue, insomnia, and stress in people with multipl…
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis [NA]
A completed clinical trial evaluated the effect of natalizumab (Tysabri) on sexual dysfunction in people with multiple sclerosis; results we…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Effects of the Cross-Training in Patients With Multiple Sclerosis [NA]
The clinical trial update indicates that the cross-training study in patients with Multiple Sclerosis has completed. No trial results are pr…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Developing and Testing a Comprehensive MS Spasticity Management Program [Phase 2]
Phase 2 update reporting completion and posting of results for a comprehensive spasticity management program in multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis [Phase 3]
Phase 3 efficacy and safety results for prolonged-release dalfampridine (dalfampridine-ER) in people with multiple sclerosis have been poste…
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Safety of RG2077 in Patients With Multiple Sclerosis [Phase 1]
Phase 1 safety update reporting on RG2077 in patients with multiple sclerosis, including relapsing-remitting multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases [NA]
A clinical trial comparing gadobutrol to gadopentetate dimeglumine or gadobenate dimeglumine before DCE-MRI in patients with multiple sclero…
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis [Phase 3]
Phase 3 study evaluating MD1003 for chronic visual loss related to optic neuritis in multiple sclerosis; current trial status is unknown.
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Effect of MD1003 in Spinal Progressive Multiple Sclerosis [Phase 3]
This document provides an update on the Phase 3 trial of MD1003 for spinal progressive multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Long-term Follow-up of Fingolimod Phase II Study Patients [Phase 4]
Long-term follow-up results from fingolimod in a Phase II study for relapsing forms of multiple sclerosis have been reported (Phase 4 update…
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Safety of Xeomin for Lower Limb Spasticity in Multiple Sclerosis Patients [Phase 4]
Phase 4 clinical trial evaluating the safety of Xeomin (incobotulinumtoxinA) for lower limb spasticity in patients with multiple sclerosis h…
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Pharmacokinetics of DMF and the Effects of DMF on Exploratory Biomarkers [Phase 4]
Phase 4 study investigating pharmacokinetics of dimethyl fumarate and its effects on exploratory biomarkers in multiple sclerosis.